Indexed annuity lawsuits are legal claims brought by customers who allege they were sold misleading or unsuitable equity-indexed annuity (EIA) products through fraud, misrepresentation, or inadequate disclosure of fees and commissions. These cases have escalated significantly since 2024, with settlements exceeding tens of millions of dollars and regulatory agencies cracking down on how these complex insurance products are marketed and illustrated to consumers. For example, Midland National settled a major class action for $31 million after plaintiffs alleged the company misrepresented the bonuses and growth potential of seven qualifying annuity products while obscuring how higher sales commissions were passed to customers through lower interest and index credits—a pattern repeated across multiple insurers and financial advisers.
The core issue is that indexed annuities are inherently complex products that promise returns tied to stock market indices while protecting principal from market losses, but plaintiffs claim insurers and brokers have systematically overstated their benefits while hiding costs. Regulatory concerns have intensified, with the National Association of Insurance Commissioners (NAIC) addressing illustrations that depict sustained annual returns of 10-25% using proprietary indices backed by favorable back-casted performance data—a method that may not reflect realistic future performance. These lawsuits represent a broader reckoning over how financial institutions sell products designed for retirement savings to consumers who may not fully understand the tradeoffs.
Table of Contents
- What Are Indexed Annuities and Why Are They Contested?
- Major Settlements and Legal Outcomes in Recent Years
- How Fraud and Misrepresentation Occur in Indexed Annuity Sales
- Regulatory Enforcement and the SEC’s Growing Focus on Indexed Annuities
- Common Claims and Legal Theories in Indexed Annuity Litigation
- The Illustration Deception Problem
- What Lies Ahead for Indexed Annuity Litigation and Regulation
- Conclusion
What Are Indexed Annuities and Why Are They Contested?
Indexed annuities are insurance products that offer a minimum guaranteed interest rate but allow customers to participate in gains tied to the performance of stock market indices like the S&P 500, typically with a participation rate cap that limits upside. Proponents argue they provide stability for retirees; critics contend they combine complexity with hidden commissions that make them poor value compared to simpler alternatives like treasury bonds or diversified mutual funds. When purchased through brokers or investment advisers, indexed annuities often carry sales commissions ranging from 5% to 10% or more—costs that are not transparently deducted upfront but instead embedded in the product structure through reduced credited interest or index participation rates. The litigation boom stems from evidence that many indexed annuities were sold as unsuitable products to conservative investors who did not need or understand them.
A retired Navy captain and his spouse sued Ameritas Mutual Holding Co. and Ameritas life Insurance Co. after alleging they were sold unsuitable equity-indexed annuities without adequate disclosure—and discovered the firm had concealed a broker’s felony aggravated assault charge. Such cases reveal that suitability failures often compound with other misrepresentations about bonuses, growth rates, and fees. Unlike plain-vanilla life insurance, indexed annuities appeal to salespeople partly because they generate higher commissions, creating an inherent incentive misalignment that plaintiffs argue sellers have exploited.
Major Settlements and Legal Outcomes in Recent Years
The Midland National settlement illustrates the scale of indexed annuity litigation. In this case, Midland National agreed to pay $31 million to settle a class action brought by customers who purchased seven qualifying annuity products and alleged misrepresentation of bonuses and growth that obscured the true cost of higher sales commissions. The settlement suggests courts and regulators increasingly view indexed annuity marketing as problematic when illustrations or sales materials imply guaranteed returns or omit how commissions reduce net credited rates.
Notably, the settlement was not an admission of wrongdoing but resolved the dispute without trial, a pattern seen across indexed annuity litigation as companies weigh the cost of fighting claims against the reputational and financial risk of losing at trial. A second major case involved Pacific Life and its Pacific Discovery Xelerator indexed universal life insurance product, where plaintiffs in California alleged the company used misleading illustrations showing inflated profitability for policies sold between 2016 and 2019. The settlement process for Pacific Discovery Xelerator illustrates how indexed product litigation evolves: claims often take years to prosecute, involve technical actuarial disputes over how illustrations were constructed, and may not be resolved until years after the sale. For investors harmed by this product, the April 10, 2026 claim deadline represents a critical deadline to join or file a claim, underscoring how indexed annuity litigation proceeds through formal settlement channels with strict claim periods.
How Fraud and Misrepresentation Occur in Indexed Annuity Sales
Misrepresentation in indexed annuity sales typically centers on three areas: understating commissions and fees, overstating guaranteed returns or bonus features, and downplaying caps or participation rate limits that reduce actual index credit. A common tactic involves presenting illustrations that show historical index performance applied to the customer’s principal over several years—a projection that obscures that future performance may differ sharply and that annual caps or fees will reduce credited returns. For example, an illustration might show the S&P 500 returned 10% annually over the past decade and use that to imply a customer’s indexed annuity would credit close to that rate, ignoring that the actual participation rate might be capped at 50% or that an annual fee of 1-2% is deducted before crediting returns.
Another frequent claim is that sellers omitted or minimized the surrender period, which typically runs 7-10 years and imposes escalating surrender charges if the customer withdraws funds early. Plaintiffs argue this feature is downplayed during sales, meaning customers who need emergency access to their money discover too late that they face substantial penalties. Additionally, some cases allege that bonuses—such as a 5% or 10% upfront credit—were presented as “free money” when they actually represent reduced future credited rates or higher fees. The SEC’s enforcement action against an investment adviser firm that sold fixed indexed annuities illustrates this dynamic: the adviser concealed substantial commissions from customers and recommended unsuitable FIAs while claiming they were appropriate for the clients’ conservative objectives.
Regulatory Enforcement and the SEC’s Growing Focus on Indexed Annuities
The SEC has intensified enforcement against investment advisers who recommend fixed indexed annuities without adequate disclosure. In one jury decision, the SEC secured a verdict against an investment adviser firm and its representative for breaching fiduciary duties through inadequate disclosure of substantial commissions from FIA sales. This case is significant because it clarifies that registered investment advisers—not just insurance agents—can face SEC enforcement if they recommend indexed annuities without transparent cost disclosure and suitability justification. The case sends a signal that advisers cannot hide behind the complexity of these products or rely on boilerplate disclaimers.
An ongoing SEC case, SEC v. Cutter, seeks to expand the regulatory obligations of registered investment advisers who are also state-licensed insurance agents. This litigation aims to establish clearer rules on when advisers must disclose their insurance commissions and when recommending an FIA becomes unsuitable based on the client’s profile. The case reflects broader regulatory concern that the dual-licensed model—whereby an individual holds both SEC registration as an adviser and state insurance licensing—creates conflicts of interest that may not be properly managed. If the SEC prevails, the outcome could significantly restrict how and when investment advisers can sell indexed annuities.
Common Claims and Legal Theories in Indexed Annuity Litigation
Indexed annuity lawsuits typically rest on several legal theories: breach of fiduciary duty (for advisers), violations of state consumer protection laws, fraud, negligent misrepresentation, and breach of contract. Plaintiffs argue that sellers owed a duty to recommend suitable products and to disclose all material facts about costs, risks, and returns—duties that were breached when indexed annuities were sold to conservative investors seeking capital preservation or when illustrations systematically overstated projected returns. A critical issue is whether the plaintiff can show the seller knew the projections were misleading or should have known they were unrealistic given market conditions and the product’s structure.
Another legal lever is the concept of suitable recommendations. Under industry rules and state law, securities and insurance professionals must recommend products suitable for the customer’s age, financial situation, risk tolerance, and objectives. When a 75-year-old with $500,000 saved for living expenses is sold an indexed annuity with a 10-year surrender period, a 1.5% annual fee, and a 50% participation cap, courts have increasingly questioned whether the sale met suitability standards—especially if simpler, lower-cost alternatives existed. The common outcome is that plaintiffs do not need to prove the seller acted with criminal intent; showing negligence or recklessness in recommending an unsuitable product often suffices for liability.
The Illustration Deception Problem
The NAIC’s spring 2026 national meeting highlighted serious concerns about how indexed annuity illustrations are constructed. Regulators identified that illustrations often depict sustained annual returns of 10-25% for the indexed portion, supported by proprietary indices that use favorable back-casted performance data—meaning the index was constructed to look good in hindsight, not tested prospectively. When a customer sees an illustration using historical S&P 500 data combined with a proprietary index that happens to show 12% annual returns over the review period, the psychological effect is powerful: the customer believes the indexed annuity will deliver returns comparable to stock market investing with no downside. The reality is often stark: due to caps, participation rate limits, and fees, actual returns average 2-4% annually, a fraction of what illustrations suggest.
This illustration issue is not merely a marketing problem—it is the linchpin of indexed annuity fraud cases. Plaintiffs’ attorneys argue that misleading illustrations constitute fraudulent inducement because they caused customers to buy products they otherwise would not have purchased. If an illustration is based on back-casted index performance that differs fundamentally from prospective expectations, and the seller presented it as a reasonable projection, courts have found that fraudulent misrepresentation occurred. The challenge for defendants is that regulators themselves have not enforced consistent standards for illustration construction, leaving a gray zone where some practices appear permissible under existing rules while being attacked as deceptive in litigation.
What Lies Ahead for Indexed Annuity Litigation and Regulation
The trajectory suggests indexed annuity litigation will intensify rather than fade. As settlement amounts grow and regulatory scrutiny increases, more consumers may pursue claims, and additional plaintiff’s bar firms may target insurers and advisers who sold these products. The SEC’s ongoing enforcement actions, including SEC v. Cutter, will likely produce case law that narrows the circumstances under which advisers can recommend FIAs without triggering fiduciary liability.
At the state regulatory level, insurance commissioners are likely to adopt stricter illustration standards and requirements for written disclosure of commissions and fees—changes that may retroactively strengthen claims against companies that marketed under older, more permissive rules. A secondary issue is the rising exposure for investment advisers. Unlike insurance-licensed agents who operate under state insurance law, registered investment advisers are subject to SEC oversight and fiduciary duties that are generally stricter. As more advisers add indexed annuities to their product lineup, SEC enforcement appears poised to intensify, particularly for advisers who lack robust compliance procedures for FIA recommendations. For consumers and retirees, this evolving legal landscape means that claims once considered speculative—such as suits against advisers for recommending unsuitable indexed annuities—are increasingly likely to succeed, making it worthwhile to review whether an indexed annuity was recommended by a fiduciary and whether adequate disclosure of costs was provided.
Conclusion
Indexed annuity lawsuits address a core tension in financial markets: complex insurance products marketed to ordinary retirees as safe alternatives to stocks, yet structured with high commissions, caps on returns, lengthy surrender periods, and illustrations that may misrepresent realistic performance. The settlements by Midland National ($31 million) and others, combined with SEC enforcement actions and regulatory warnings from the NAIC, establish that courts and regulators increasingly view deceptive marketing and misrepresentation in indexed annuity sales as actionable wrongs. The common thread across litigation is that sellers failed to disclose how commissions reduced returns, overstated the bonuses and growth potential, or recommended unsuitable products to conservative investors.
If you purchased an indexed annuity and believe you were misled about its benefits, costs, or suitability, reviewing your sales materials and discussing your case with an attorney who handles indexed annuity litigation can help determine whether you have a claim. Claim deadlines in settled cases can be strict, and the window to pursue litigation is limited by statutes of repose, making timely action essential. The regulatory focus on indexed annuities shows no sign of abating, meaning that additional settlements, enforcement actions, and litigation are likely in the years ahead.